Literature DB >> 17296996

Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy.

S I Usiskin1, A Bainbridge, R F Miller, H R Jäger.   

Abstract

A patient with human immunodeficiency virus-related posterior fossa progressive multifocal leukoencephalopathy had serial diffusion-weighted imaging using b-values of 1000 and 3000 before and during highly active antiretroviral therapy (HAART). High-b-value images provided a superior definition of the leading edge of the lesion and additional information about the integrity of white matter tracts. Following HAART, there was a marked reduction of lesional apparent diffusion coefficient and reconstitution of anisotropy in the affected middle cerebellar peduncle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296996      PMCID: PMC7977434     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.

Authors:  J M Tassie; J Gasnault; M Bentata; J Deloumeaux; F Boué; E Billaud; D Costagliola
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

2.  Lesion extension detected by diffusion-weighted magnetic resonance imaging in progressive multifocal leukoencephalopathy.

Authors:  K Ohta; K Obara; M Sakauchi; K Obara; H Takane; Y Yogo
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

3.  Progressive multifocal leukoencephalopathy.

Authors:  R D Henderson; M G Smith; P Mowat; S J Read
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

Review 4.  Progressive multifocal leukoencephalopathy.

Authors:  J R Berger; E O Major
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

5.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

6.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

Authors:  M M Thurnher; M J Post; A Rieger; C Kleibl-Popov; C Loewe; E Schindler
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

7.  Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.

Authors:  M Bergui; G B Bradac; K K Oguz; A Boghi; C Geda; G Gatti; D Schiffer
Journal:  Neuroradiology       Date:  2003-10-31       Impact factor: 2.804

  7 in total
  11 in total

1.  Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.

Authors:  C Buckle; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

3.  Apparent diffusion coefficient with higher b-value correlates better with viable cell count quantified from the cavity of brain abscess.

Authors:  V Tomar; A Yadav; R K S Rathore; S Verma; R Awasthi; V Bharadwaj; B K Ojha; K N Prasad; R K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-08       Impact factor: 3.825

4.  Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study.

Authors:  R Della Nave; A Ginestroni; C Tessa; M Giannelli; S Piacentini; M Filippi; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

5.  Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection.

Authors:  Daniel S Bucy; Mark S Brown; Helle Bielefeldt-Ohmann; Jesse Thompson; Annette M Bachand; Michelle Morges; John H Elder; Sue Vandewoude; Susan L Kraft
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

Review 6.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

Review 7.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

8.  High b-value apparent diffusion-weighted images from CURVE-ball DTI.

Authors:  Sharon Peled; Stephen Whalen; Ferenc A Jolesz; Alexandra J Golby
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

Review 9.  Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.

Authors:  Justin M Honce; Lidia Nagae; Eric Nyberg
Journal:  Mult Scler Int       Date:  2015-09-21

10.  Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.

Authors:  Guglielmo Manenti; Simone Altobelli; Marco Nezzo; Marco Antonicoli; Erald Vasili; Luca Neroni; Roberto Floris; Giovanni Simonetti
Journal:  Case Rep Radiol       Date:  2013-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.